日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ZDHHC2-Dependent Palmitoylation Dictates Ferroptosis and Castration Sensitivity in Prostate Cancer via Controlling ACSL4 Degradation and Lipid Peroxidation.

ZDHHC2 依赖的棕榈酰化通过控制 ACSL4 降解和脂质过氧化来决定前列腺癌的铁死亡和去势敏感性。

ASCT2 palmitoylation regulated by JNK1-ZDHHC14 axis orchestrates glutamine metabolism and NSCLC progression.

ASCT2 棕榈酰化受 JNK1-ZDHHC14 轴调控,协调谷氨酰胺代谢和非小细胞肺癌进展。

ZDHHC9 palmitoylates LAMTOR1 to promote renal cell carcinoma malignant progression.

ZDHHC9 通过棕榈酰化 LAMTOR1 促进肾细胞癌的恶性进展。

Liu Bo, Hou Tao, Liu Xizhi, Liu Lu, Ma Zhiqiang, Zhang Yujiao

ASF1B promotes gastric cancer liver metastasis through inhibiting ZDHHC9/PCBP1/ SLC7A11 signaling axis mediated ferroptosis.

ASF1B 通过抑制 ZDHHC9/PCBP1/SLC7A11 信号轴介导的铁死亡促进胃癌肝转移。

Wang Mingliang, Yu Kexun, Ma Mengdi, Li Jing, Zhang Ying, Ke Zhangyan, Wang Huizhen, Li Yongxiang

ZDHHC4-mediated ZEB-2 S-palmitoylation promotes melanoma epithelial-mesenchymal transition via deubiquitinating and stabilizing ZEB-2.

ZDHHC4 介导的 ZEB-2Â S-棕榈酰化通过去泛素化和稳定 ZEB-2 来促进黑色素瘤上皮-间质转化。

Acylation modification mediated post-translational modifications learning signature reveals ZDHHC18 promotes progression of lung adenocarcinoma by attenuating immunocyte activation

酰化修饰介导的翻译后修饰学习特征揭示ZDHHC18通过减弱免疫细胞活化促进肺腺癌进展。

Xiao, Qifan; Bu, Jianlong; Liu, Mengfeng; Shi, Lei; Qu, Changfa

Anatid herpesvirus 1 UL51 protein is palmitoylated by DHHC9 and DHHC18 for viral replication and virulence.

鸭疱疹病毒 1 UL51 蛋白通过 DHHC9 和 DHHC18 进行棕榈酰化,以促进病毒复制和毒力。

Liu Xiaolan, Zhang Ruihao, Wang Mingshu, Cheng Anchun, Zhang Wei, Yang Qiao, Ou Xumin, Sun Di, He Yu, Tian Bin, Wu Zhen, Zhang Shaqiu, Huang Juan, Wu Ying, Yu Yanling, Zhang Ling, Zhao XinXin, Zhu Dekang, Chen Shun, Jia Renyong, Liu Mafeng

SREBP2-RAB11A-ZDHHC20 axis orchestrates FGFR3 palmitoylation and membrane retention to drive bladder cancer progression.

SREBP2-RAB11A-ZDHHC20 轴协调 FGFR3 棕榈酰化和膜滞留,从而驱动膀胱癌进展。

Metabolic orchestration of NOD1 signaling by AMPK-mediated phosphorylation of ZDHHC5.

AMPK介导的ZDHHC5磷酸化对NOD1信号进行代谢调控。

Mi Shaojie, Zhu Yue, Li Qian, Zhang Wanjun, Pei Huadong, Yao Feng, Guo Xuewu, Chen Yali

Author Correction: ZDHHC9 promotes osteosarcoma progression via KRAS-associated enhancement of the RAS/MAPK signaling pathway

作者更正:ZDHHC9 通过 KRAS 相关增强 RAS/MAPK 信号通路促进骨肉瘤进展。

Li, Zhixiang; Li, Jiarui; Wu, Yuanyuan; Luo, Yanhai; Zheng, Jianping; Shi, Jiandang